Suchergebnisse - "O3J8G9O825"

PubPharm (5.515)

141

Effects of nirmatrelvir/ritonavir on midazolam and dabigatran pharmacokinetics in healthy participants

enthalten in: British journal of clinical pharmacology | 2023

von Cox, D. | Rehman, M. | Khan, T. | +5

142

Related factors of viral nucleic acid change in critically ill patients with SARS-CoV-2 infection after treatment with Nirmatrelvir/Ritonavir : a single center retrospective cohort study

enthalten in: Zhonghua wei zhong bing ji jiu yi xue | 2023

von Yan, M. | Xie, M. | Zhu, S. | +2

143

The effect of ritonavir on the pharmacokinetics of clonidine in vivo and in vitro

enthalten in: Pakistan journal of pharmaceutical sciences | 2023

von Wang, P. | Hu, X.

144

Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir

enthalten in: Biochemical and biophysical research communications | 2023

von Caronia, L. | Xi, R. | Margolskee, R. | +1

145

Evaluating pediatric tuberculosis dosing guidelines : A model-based individual data pooled analysis

enthalten in: PLoS medicine | 2023

von Galileya, L. | Wasmann, R. | Chabala, C. | +11

146

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Chan, G. | Lui, G. | Wong, C. | +6

147

Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 Years

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Faust, J. | Kumar, A. | Shah, J. | +4

148

Nirmatrelvir/ritonavir and risk of long COVID symptoms : a retrospective cohort study

enthalten in: Scientific reports | 2023

von Congdon, S. | Narrowe, Z. | Yone, N. | +7

149

Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Lanzafame, M. | Gottardi, M. | Guella, L. | +4

150

Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities : A propensity score-matched territory-wide study

enthalten in: Travel medicine and infectious disease | 2023

von Liu, S. | Shen, X. | Zhang, F. | +4